Seventeen years ago, Silicon Valley veteran Patañjali Chary lost his mother to acute kidney failure - a preventable tragedy. He founded Fourth Vital to revolutionize the detection and management of chronic kidney disease (CKD).

CKD is irreversible. Yet most cases can be avoided with early intervention. 90% of people with the condition remain unaware until it's too late. Current diagnostic methods, such as blood and urine tests, identify CKD only in its advanced stages - when treatment can slow progression, but not prevent the inevitable suffering. By 2034, CKD is projected to affect over 15% of the global population, with treatment costs exceeding USD $1.6 trillion annually.

Fourth Vital is revolutionizing CKD prevention with cutting-edge AI-powered early-warning systems and an innovative, non-invasive wearable device designed for home use. Built on clinically validated methodologies, this breakthrough technology seamlessly integrates physiological and social biomarkers to detect early-stage patterns that conventional diagnostics often overlook.

Fourth Vital has crafted advanced analytics, intuitive visualizations, and user-friendly tools to help physicians treating patients with CKD.

Our mission is to improve the quality of life for millions while reducing healthcare costs by over USD $150 billion annually in the United States alone.